Watts Ryan J. sold DNLI
July 9, 2025 · Form 4 insider transaction
Watts Ryan J. sold 495,282 shares of Denali Therapeutics Inc. at $15.00 per share, a transaction worth $7.43M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The sales reported by the Reporting Person were made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 09/16/2024. The shares sold primarily relate to 455,282 stock options that expire on 08/21/2025.; The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $15.00 to $15.08 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.; Includes 177,940 Unvested RSUs.